← SynDRA
FRUQUINTINIB
SynDRA canonical compound SYN0039840 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | KDR |
|---|
| Mechanism of action | VEGFR inhibitor |
|---|
| Indication | colorectal cancer |
|---|
| Disease area | oncology |
|---|
All known targets
Mechanisms of action (all sources)
- FLT1 INHIBITOR
- Vascular endothelial growth factor receptor inhibitor
- FLT4 INHIBITOR
- KDR INHIBITOR
- VEGFR inhibitor
Drug classes
- Antineoplastic Agents
- Tyrosine Kinase Inhibitors
ATC classes
- L01E · PROTEIN KINASE INHIBITORS
Cross-references
Synonyms
- HMPL-013
- HMPL013
- Fruzaqla
- fruquintinibum
- Elunate
- RefChem:141565
- VEGFR-1/2/3 Inhibitor HMPL-013
- Fruquintinib [WHO-DD]
- Fruquintinib [USAN]
- MFCD28502149
- UNII-49DXG3M5ZW
- Fruzaqla (TN)
- Fruquintinib (Standard)
- Fruquintinib (JAN/USAN)
- FRUQUINTINIB [INN]
- Fruquintinib; HMPL-013
- Fruquintinib (HMPL-013)
- Fruquintinib (HMPL-013)?
- SCHEMBL947183
- Fruquintinib [USAN:WHO-DD]
- GTPL9428
- orb1305210
- SCHEMBL29366206
- SCHEMBL29516397
- BALLNEJQLSTPIO-UHFFFAOYSA-N
- CHEBI:229221
- GLXC-90366
- HMS5085C11
- EX-A2262
- BDBM50637221
- HY-19912R
- NSC801000
- NSC829498
- s5667
- WHO 10348
- AKOS026750586
- CCG-268573
- CS-5558
- NSC-801000
Look up FRUQUINTINIB in the interactive SynDRA portal →